Te­va and No­var­tis’ San­doz launch Nar­can gener­ics on same day, brand mar­keter Emer­gent re­mains in play

4 years ago
Pharma
Marketing

FDA+ roundup: Agency re­struc­tures chief sci­en­tist's of­fice; First vote on Rob Califf as com­mis­sion­er pushed to next ...

4 years ago
FDA+

Spec­trum hits the re­set but­ton, slic­ing away 30% of its work­force in piv­ot around 2 lead as­sets

4 years ago
People
R&D

An­nex­on shares fall 33% af­ter pa­tients drop out of Hunt­ing­ton's tri­al; Two Chi­nese biotechs net mod­est fi­nanc­ing ...

4 years ago
News Briefing

Clover Bio­phar­ma­ceu­ti­cals sets up a new R&D cen­ter in a buzzy Chi­nese hub near Shang­hai

4 years ago
R&D
China

Blue­print­'s long­time CEO pre­pares to step down as biotech rev­els in new Ay­vak­it launch, pipeline ex­pan­sion

4 years ago
People

Catal­ent CEO John Chimin­s­ki set to pass the torch this sum­mer af­ter 12 years at the helm

4 years ago
People
Manufacturing

Gene ther­a­py play­er Affinia aims to go pub­lic, hop­ing to raise big mon­ey in ef­fort to re­make AAVs

4 years ago
Financing
Cell/Gene Tx

Can RNA edit­ing take At­las start­up where Ver­tex could­n't go? Ko­r­ro lands $116M to find out

4 years ago
Financing
Cell/Gene Tx

Gene ther­a­py 3.0 ef­forts net Sali­o­Gen a nine-fig­ure Se­ries B, but much re­mains un­der wraps

4 years ago
Financing
Cell/Gene Tx

Tak­ing notes from MD An­der­son and Rice Uni­ver­si­ty, Avenge Bio un­cloaks with $45M and a slate of im­munother­a­pies

4 years ago
Financing
Startups

BioN­Tech and Pfiz­er an­nounce $225M shin­gles vac­cine project, of­fer­ing mR­NA chal­lenger to Glax­o­SmithK­line's Shin­grix

4 years ago
Deals

FDA paus­es do­mes­tic drug in­spec­tions again, this time to pro­tect against Omi­cron

4 years ago
FDA+
Manufacturing

In­side the multi­bil­lion-dol­lar, Sil­i­con Val­ley-backed ef­fort to reimag­ine how the world funds (and con­ducts) sci­ence

4 years ago
Discovery
In Focus

Third for­mer GSK sci­en­tist pleads guilty to con­spir­ing to steal trade se­crets

4 years ago
People
Pharma

Q&A: Com­mer­cial vet­er­an Su­san Sweeney mo­bi­lizes decades of drug launch ex­pe­ri­ence at Am­gen

4 years ago
Pharma
Marketing

Mar­ket­ingRx roundup: Pfiz­er pro­pos­es New Year's res­o­lu­tions; BMS de­buts TV ad for Zeposia in ul­cer­a­tive col­i­tis

4 years ago
Pharma
Marketing

CSL's Se­qirus flu vac­cine cam­paign keeps ‘twindem­ic’ dan­ger of Covid-19 and sea­son­al flu on front burn­er

4 years ago
Pharma
Marketing

Ei­sai’s art-dri­ven MBC project con­tin­ues with new ‘fear­LESS’ theme draw­ing on pa­tients’ in­di­vid­ual sto­ries

4 years ago
Pharma
Marketing

US restarts ship­ments of two mAbs that don't work against Omi­cron as Mer­ck pills see wider dis­tri­b­u­tion

4 years ago
Coronavirus

As­traZeneca hands off epilep­sy pro­grams to Ovid; Amy­lyx scores pri­or­i­ty re­view for ALS drug 

4 years ago
News Briefing

Eu­ro­pean biotech VC clos­es first fund with over $120M in the bank, thanks to big in­vestors

4 years ago
Financing

In­di­an CD­MO Pi­ra­mal Phar­ma to up in vit­ro ca­pa­bil­i­ties at ex­ist­ing site

4 years ago
Manufacturing

Bio­gen bets $60M up­front that a new an­ti­sense can­di­date from Io­n­is can one-up Spin­raza

4 years ago
Deals
First page Previous page 603604605606607608609 Next page Last page
A service from the Financial Times